Search Within

Rona Denit Yaeger

Formats
  1. Meeting Abstract (166)
  2. Journal Article (143)
  3. Review (7)
  4. Editorial (6)
  5. Research Letter (4)
  6. Book Section (1)
  7. Correspondence (1)
  8. Guidelines (1)
Groups
  1. Department of Medicine (329)
  2. Gastrointestinal Oncology Service (329)
  3. Solid Tumor Oncology Division (329)
  4. Center for Pancreatic Cancer Research (136)
  5. GSK Faculty (134)
  6. Department of Pathology and Laboratory Medicine (125)

More Groups

People
  1. Andrea Cercek Hanjis (95)
  2. Leonard Saltz (81)
  3. Jinru Shia (76)
  4. Martin Weiser (64)
  5. Zsofia Stadler (62)
  6. Julio Garcia Aguilar (61)

More People

Years
  1. 2025 (29)
  2. 2024 (41)
  3. 2023 (37)
  4. 2022 (39)
  5. 2021 (36)
  6. 2020 (28)

More Years

Publications
  1. Journal of Clinical Oncology (101)
  2. Annals of Oncology (37)
  3. Clinical Cancer Research (17)
  4. Cancer Research (15)
  5. Cancer Discovery (14)
  6. Nature Medicine (9)

More Publications

Publishers
  1. American Society of Clinical Oncology (111)
  2. American Association for Cancer Research (51)
  3. Oxford University Press (48)
  4. Nature Publishing Group (26)
  5. Elsevier Inc. (19)
  6. Springer (10)

More Publishers

Results (329)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Using mutational load in next generation sequencing (NGS) to identify mismatch repair (MMR) deficiency in colorectal cancer (CRC)
    Meeting Abstract

    Battaglin, F.; Stadler, Z. K.; Cercek, A.; Yaeger, R. D.; Segal, N. H.; Varghese, A. M.; Kemeny, N. E.; Weiser, M. R.; Garcia-Aguilar, J.; Shia, J.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Immunohistochemical detection of the BRAF V600E mutant protein in colorectal neoplasms
    Journal Article

    Vakiani, E.; Yaeger, R.; Brooke, S.; Zhou, Y.; Klimstra, D. S.; Shia, J.
    Applied Immunohistochemistry & Molecular Morphology (2015)

    Fulltext@MSK | Save
  • Pilot study of vemurafenib and panitumumab combination therapy in patients with BRAF V600E mutated metastatic colorectal cancer
    Meeting Abstract

    Yaeger, R. D.; Cercek, A.; O'Reilly, E. M.; Reidy, D. L.; Kemeny, N. E.; Wolinsky, T.; Gollub, M. J.; Lacouture, M. E.; Rosen, N.; Vakiani, E.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Pilot trial of combined BRAF and EGFR inhibition in BRAF-mutant metastatic colorectal cancer patients
    Journal Article

    Yaeger, R.; Cercek, A.; O'Reilly, E. M.; Reidy, D. L.; Kemeny, N.; Wolinsky, T.; Capanu, M.; Gollub, M. J.; Rosen, N.; Berger, M. F.; more...
    Clinical Cancer Research (2015)

    Fulltext@MSK | Save
  • RAS mutations affect pattern of metastatic spread and increase propensity for brain metastasis in colorectal cancer
    Journal Article

    Yaeger, R.; Cowell, E.; Chou, J. F.; Gewirtz, A. N.; Borsu, L.; Vakiani, E.; Solit, D. B.; Rosen, N.; Capanu, M.; Ladanyi, M.; more...
    Cancer (2015)

    Fulltext@MSK | Save
  • Comprehensive assessment of RAS/RAF mutation status and identification of alternative targetable driver alterations in RAS/RAF wild type colorectal carcinoma using a hybrid capture-based next-generation sequencing assay
    Meeting Abstract

    Hechtman, J.; Zehir, A.; Cheng, D.; Shia, J. R.; Solit, D.; Yaeger, R.; Hyman, D.; Arcila, M.; Berger, M.; Ladanyi, M.; more...
    Modern Pathology (2015)

    Fulltext@MSK | Save
  • Comprehensive assessment of RAS/RAF mutation status and identification of alternative targetable driver alterations in RAS/RAF wild type colorectal carcinoma using a hybrid capture-based next-generation sequencing assay
    Meeting Abstract

    Hechtman, J.; Zehir, A.; Cheng, D.; Shia, J.; Solit, D.; Yaeger, R.; Hyman, D.; Arcila, M.; Berger, M.; Ladanyi, M.; more...
    Laboratory Investigation (2015)

    Fulltext@MSK | Save
  • AKT1 E17K in colorectal carcinoma is associated with BRAF V600E but not MSI-H status: A clinicopathologic comparison to PIK3CA helical and kinase domain mutants
    Meeting Abstract

    Hechtman, J.; Sadowska, J.; Huse, J.; Borsu, L.; Yaeger, R.; Shia, J. R.; Vakiani, E.; Ladanyi, M.; Arcila, M.
    Laboratory Investigation (2015)

    Fulltext@MSK | Save
  • AKT1 E17K in colorectal carcinoma is associated with BRAF V600E but not MSI-H status: A clinicopathologic comparison to PIK3CA helical and kinase domain mutants
    Meeting Abstract

    Hechtman, J.; Sadowska, J.; Huse, J.; Borsu, L.; Yaeger, R.; Shia, J.; Vakiani, E.; Ladanyi, M.; Arcila, M.
    Modern Pathology (2015)

    Fulltext@MSK | Save
  • Phase I study of the selective BRAFV600 inhibitor encorafenib (LGX818) combined with cetuximab and with or without the α-specific PI3K inhibitor alpelisib (BYL719) in patients with advanced BRAF mutant colorectal cancer
    Meeting Abstract

    Tabernero, J.; van Geel, R.; Bendell, J. C.; Spreafico, A.; Schuler, M.; Yoshino, T.; Delord, J. P.; Yamada, Y.; Lolkema, M. P.; Fans, J. E.; more...
    European Journal of Cancer (2014)

    Fulltext@MSK | Save